Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: HIV Glasgow: Generic Hepatitis C Drugs Purchased Online Produce High Cure Rates
Tig


Admin

Status: Offline
Posts: 9101
Date:
RE: HIV Glasgow: Generic Hepatitis C Drugs Purchased Online Produce High Cure Rates
Permalink  
 


Thanks HieuPham,

Interesting statistics and data in that article. If we can get our respective countries to relax the customs and patent rights issues that would make these medications easier to access. We should all hope for the day that these effective and cost saving drugs can be obtained everywhere. It's getting easier, but there is still work to be done. 



__________________

Tig

63 yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 6+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 



Newbie

Status: Offline
Posts: 2
Date:
Permalink  
 

Hi all,

I am new here. This is the article I just saw. Hope to share it as a "Hello"

Use of generic versions of direct-acting antivirals for hepatitis C resulted in very high cure rates for people who obtained the products through 3 buyers clubs, indicating that the generic products are effective, according to a set of poster presentations at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) last week. People who purchased generic drugs were cured at a cost of around US$700-$900 in Southeast Asia and Eastern Europe, Andrew Hill of St. Stephens AIDS Trust reported.

HIV Glasgow:HCV Generic Success

Cheers!



-- Edited by Tig56 on Thursday 3rd of November 2016 09:07:55 AM

__________________
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.